Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 111316001000001113 | Risedronate sodium (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 111316101000001114 | Risedronate sodium | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Risedronate sodium | Is a | Product containing risedronic acid | true | Inferred relationship | Existential restriction modifier | ||
| Risedronate sodium | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Risedronate sodium | Has active ingredient | Risedronic acid | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Risedronate sodium 35mg/5ml oral solution | Is a | True | Risedronate sodium | Inferred relationship | Existential restriction modifier | |
| Risedronate sodium 35mg/5ml oral suspension | Is a | True | Risedronate sodium | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR